A national survey of the infectious diseases and antimicrobial stewardship pharmacist workforce in the United States: work settings, characteristics, employment activities, resources and needs
Abstract Purpose: This national survey aimed to describe the work settings, characteristics, employment activities, scope, functions, and challenges of the pharmacist workforce responsible for infectious diseases (ID) and antimicrobial stewardship (AMS)-related tasks in the U.S. Methods: An internet-based Qualtrics XM survey was distributed to 22,749 unique individuals with potential ID or AMS job responsibilities via email listservs for three national pharmacy organizations, and was open from 9/25/2024 to 10/24/2024. A respondent was considered engaged in ID/AMS activities if they reported involvement in at least one of 14 activities directly related to ID/AMS. Results: A total of 796 pharmacists with ID or AMS job responsibilities responded (3.5% response rate), with 607 working clinically or administratively in ID or AMS further categorized in four mutually exclusive groups based on formal and informal ID/AMS responsibilities. Respondents were predominantly female (66%), less than 40 years of age (59%) and white (82%). ID-specific training was completed by 41.8%, and 74% reported having student loan debt at graduation. Work-related activities were diverse and most frequently included: staffing or taking calls on weekends related to ID/AMS, AMS, educating learners or healthcare providers about ID-related topics, precepting learners, and conducting ID-related research and/or quality improvement projects. Respondents frequently indicated they lacked adequate job resources. Conclusions: The results highlight the extensive responsibilities placed on ID/AMS pharmacists to fulfill multiple roles. Pharmacists frequently lack ID-specific training or dedicated time for AMS responsibilities. The workforce is young, suggesting a need for both increased capacity for training programs and strategies for workforce retention.
Authors
- Margo S. Farber
- Mary S. Hayney (ORCID: https://orcid.org/0000-0003-3307-5634)
- Scott Bergman (ORCID: https://orcid.org/0000-0002-6466-9518)
- Whitney R. Buckel (ORCID: https://orcid.org/0000-0001-9505-2572)
- Melanie R. Nicol (ORCID: https://orcid.org/0000-0001-5513-5509)
- Elizabeth B. Hirsch (ORCID: https://orcid.org/0000-0002-0462-0421)
- Alan E. Gross (ORCID: https://orcid.org/0000-0001-9352-8389)
- Vicki Basalyga
- Aaron M. Gilson (ORCID: https://orcid.org/0000-0002-3627-9627)
- Kathryn DeSear (ORCID: https://orcid.org/0000-0002-9042-9075)
- Jamie L. Wagner (ORCID: https://orcid.org/0000-0002-6006-7894)
- Caroline A. Gaither (ORCID: https://orcid.org/0000-0001-5247-2497)
- Tracy N. Zembles (ORCID: https://orcid.org/0000-0003-3727-7970)
- Samuel L Aitken (ORCID: https://orcid.org/0000-0002-8659-4238)
- David A. Mott
- Erin K. McCreary
- Melissa D. Johnson
- Warren E. Rose
- Jon C. Schommer
Institutions
- Intermountain Healthcare (US)
- Children's Hospital of Wisconsin (US)
- Mount Auburn Hospital (US)
- University of Minnesota (US)
- Nebraska Medical Center (US)
- Florida Department of Education (US)
- University of Wisconsin–Madison (US)
- University of Pittsburgh (US)
- Wayne State University (US)
- American Association of Colleges of Pharmacy (US)
- University of Michigan (US)
- University of Minnesota System (US)
- American Society of Health-System Pharmacists (US)
- University of Illinois Chicago (US)
- Twin Cities Orthopedics (US)
- Duke University Hospital (US)
Publication Details
- Journal
- Antimicrobial Stewardship & Healthcare Epidemiology
- Published
- 2026-01-01
- DOI
- https://doi.org/10.1017/ash.2026.10312
- Primary Topic
- Antibiotic Use and Resistance
- Type
- article
- Field-Weighted Citation Impact
- 0.00